BioSpace News Archive

Predictive Oncology Inc. announced that it entered into a $15 million common stock purchase and registration rights agreement with Oasis Capital, LLC, a Puerto Rico limited liability company, to purchase from the Company up to Fifteen Million Dollars of the Company’s Common Stock.

BTIG announced today that Camilo Lyon has joined the firm’s Research and Strategy division to launch coverage across the consumer sector, focusing on lifestyle and wellness brands. He will be based in the firm’s New York office, and will report to David Lenchus, Director of Research at BTIG.

Prebiotin® Prebiotic Fiber has joined True Health Initiative (THI), a global group of experts with the mission of “Creating a world free of preventable disease.”

Partnering with Altoida, Inc. to Leverage Predictive Digital Biomarkers for Detection of Mild Cognitive Impairment due to Alzheimer’s Disease

Canopy and Neptune mutually decided to review the terms of their processing agreement.

Technavio has announced its latest market research report titled global infection control market 2020-2024

Highmark Health announced today that through its VITAL Innovation Platform, it is testing Moving Analytics’ MOVN virtual cardiac rehabilitation solution for delivering cardiac rehab remotely to patients with heart disease.

Market leaders in industrial automation and simulation help customers realize better business outcomes through simulation-based digital twins

VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today announced the results of a clinical study (NCT02553824) demonstrating that patients with binge-eating disorder (BED) or bulimia nervosa (BN) receiving Qsymia (phentermine and topiramate extended-release (ER)) capsules CIV had a significant reduction in binge day frequency compared with placebo over four weeks

Hologic, Inc. announced that it has entered into a definitive agreement to sell its Cynosure medical aesthetics business to an affiliate of investment funds managed by Clayton, Dubilier & Rice for a total purchase price of $205 million in cash, subject to certain closing adjustments.